Regional Structure

North America is the current commercial market, with active physician adoption, FDA-cleared operations, and recurring procedure-based revenue generation.

• FDA clearance in place
• Active physician network — 65+ centers (100% year-over-year growth)
• 15,500+ procedures performed
• Multi-state deployment, expanding 2026

Government and military channels are being evaluated through targeted institutional relationships and potential contracted adoption pathways.

• VA system engagement underway
• Federal contracting pathway identified
• Structured per-procedure pricing model applicable
• Institutional adoption discussions active

Medfiniti maintains permanent establishment in Amsterdam, the Netherlands, operated by HemWell MD B.V. This office serves as the European commercial anchor and regional coordination hub for Europe and the GCC.

• Permanent establishment in Amsterdam (Louwesweg 6)
• HemWell MD B.V. — European & GCC entity operational
• Managing Director in place — active market development
• Foundation for broader European regulatory and commercial pathway

Europe represents a planned regional expansion market, anchored by the Amsterdam office, with broader commercialization to follow through distributor-led partnerships.

• Netherlands permanent establishment in place as regional anchor
• Broader European regulatory pathway under assessment
• Distributor relationships under evaluation
• Reimbursement feasibility review in progress

Selected Gulf markets are under evaluation as part of a broader regional expansion strategy built around partnership-led market entry.

• Dubai and Riyadh as priority markets
• Regional partner model under development
• Private healthcare demand well-established
• Commercial feasibility review in progress